Rivastigmine Film, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Rivastigmine Film, Extended Release (film, extended release) from Mylan Pharmaceuticals Inc., A Viatris Company with status To Be Discontinued. The shortage was first posted on Sep 18, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Mylan Pharmaceuticals Inc., A Viatris Company
- Package NDC
- 0378-9070-93
- Dosage Form
- Film, Extended Release
- Presentation
- Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)
- Initial Posting
- Sep 18, 2026